scispace - formally typeset
W

Weiwei Li

Researcher at Scripps Research Institute

Publications -  17
Citations -  2079

Weiwei Li is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Serine hydrolase & Cannabinoid receptor. The author has an hindex of 13, co-authored 14 publications receiving 1886 citations. Previous affiliations of Weiwei Li include National University of Singapore & Stanford University.

Papers
More filters
Journal ArticleDOI

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

TL;DR: 2-AG endogenously modulates several behavioral processes classically associated with the pharmacology of cannabinoids and point to overlapping and unique functions for 2-AG and anandamide in vivo, indicating a functional segregation of endocannabinoid signaling pathways in vivo.
Journal ArticleDOI

Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening

TL;DR: It is shown here that the vast majority of mammalian metabolic SHs can be labeled in proteomes by a single, active site-directed fluorophosphonate probe, and it is shown that lead carbamate inhibitors can be optimized into pharmacological probes that inactivate individual SHs with high specificity in vivo.
Journal ArticleDOI

A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases

TL;DR: A functional proteomic strategy to systematically develop potent and selective inhibitors for uncharacterized serine hydrolases and its application to the brain-enriched enzyme α/β-hydrolase-6 is described.
Journal ArticleDOI

Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes

TL;DR: Treatment of two mouse models of obesity-diabetes with a Ces3 inhibitor ameliorates multiple features of metabolic syndrome, illustrating the power of the described strategy to accelerate the identification and pharmacologic validation of new therapeutic targets.